Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery

被引:35
作者
Bhavane, R
Karathanasis, E
Annapragada, AV
机构
[1] Cleveland State Univ, Dept Chem Engn, Cleveland, OH 44115 USA
[2] Cleveland State Univ, Appl Biomed Engn Program, Cleveland, OH 44115 USA
[3] Cleveland Clin Fdn, Cleveland, OH 44115 USA
关键词
agglomerated vesicle technology; aerosol drug delivery; controlled and modulated release; liposomes; ciprofloxacin; GRAFTED LIPOSOMES; POROUS PARTICLES; INHALED INSULIN; NEBULIZATION;
D O I
10.1016/S0168-3659(03)00359-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new class of pulmonary delivery particles is described. These particles consist of multimicron sized chemically linked agglomerates of core nanoparticles. The links between the nanoparticles can be either permanent (e.g. carbonyl) or cleavable (e.g. disulfide or ester). Complex agglomerate structures can be achieved by scheduling the application of linker agents. The release rate of drugs from the assembly can be modulated by controlling the extent of cleavage of the links. One envisions the structure of the agglomerate during cleavage being controlled by the location of the permanent and cleavable links in the agglomerate. Data on the release of ciprofloxacin from these agglomerates in vitro are presented. (C) 2003 Published by Elsevier B.V.
引用
收藏
页码:15 / 28
页数:14
相关论文
共 30 条
[1]  
Adjei AL., 1997, INHALATION DELIVERY
[2]   Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract [J].
Bot, AI ;
Tarara, TE ;
Smith, DJ ;
Bot, SR ;
Woods, CM ;
Weers, JG .
PHARMACEUTICAL RESEARCH, 2000, 17 (03) :275-283
[3]  
BRADY RM, 1984, NATURE, V309, P225, DOI 10.1038/309225a0
[4]   An investigation of some of the factors influencing the jet nebulisation of liposomes [J].
Bridges, PA ;
Taylor, KMG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 204 (1-2) :69-79
[5]   Aerosol delivery of liposome-encapsulated ciprofloxacin: Aerosol characterization and efficacy against Francisella tularensis infection in mice [J].
Conley, J ;
Yang, HM ;
Wilson, T ;
Blasetti, K ;
DiNinno, V ;
Schnell, G ;
Wong, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1288-1292
[6]   Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features [J].
Dailey, LA ;
Schmehl, T ;
Gessler, T ;
Wittmar, M ;
Grimminger, F ;
Seeger, W ;
Kissel, T .
JOURNAL OF CONTROLLED RELEASE, 2003, 86 (01) :131-144
[7]   Hollow porous particles in metered dose inhalers [J].
Dellamary, LA ;
Tarara, TE ;
Smith, DJ ;
Woelk, CH ;
Adractas, A ;
Costello, ML ;
Gill, H ;
Weers, JG .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :168-174
[8]   A facile method of delivery of liposomes by nebulization [J].
Desai, TR ;
Hancock, REW ;
Finlay, WH .
JOURNAL OF CONTROLLED RELEASE, 2002, 84 (1-2) :69-78
[9]   Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles [J].
Dunne, M ;
Corrigan, OI ;
Ramtoola, Z .
BIOMATERIALS, 2000, 21 (16) :1659-1668
[10]   Large porous particles for pulmonary drug delivery [J].
Edwards, DA ;
Hanes, J ;
Caponetti, G ;
Hrkach, J ;
BenJebria, A ;
Eskew, ML ;
Mintzes, J ;
Deaver, D ;
Lotan, N ;
Langer, R .
SCIENCE, 1997, 276 (5320) :1868-1871